Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691932 · ClinicalTrials.gov registry record
At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)
A clinical trial of Breastfeeding and Exclusive Breastfeeding, sponsored by University of Rochester.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06691932: Recruiting study of Breastfeeding and Exclusive Breastfeeding, sponsored by University of Rochester.
NCT06691932 is a study of Breastfeeding and Exclusive Breastfeeding that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 240 participants, below the 590-participant average among 36 other Breastfeeding trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06691932, a study of Breastfeeding and Exclusive Breastfeeding, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to define human milk (HM) as an ecosystem which investigators will then combine into temporal models of milk dynamics to accurately describe HM chronobiology. This study addresses 4 crucial public health gaps: 1) how breast milk changes over time and over the day, 2) how milk dynamics are related to infant sleep patterns, 3) how milk dynamics are related to infant microbiome dynamics, and 4) how all these relationships differ between infants fed directly at-the-breast vs pumped milk. These fundamental insights have been unknown until now, so that families who feed pumped breast milk are completely underserved. These results are critical to optimizing infant feeding and health outcomes for all infants receiving breast milk.
Primary Outcome
The time to fall asleep after bedtime(minutes)
Conditions Studied
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-11-12 |
| Est. Completion | 2029-11-01 |
What NCT06691932 shows while recruiting
NCT06691932 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 590-participant average among 36 other Breastfeeding trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Breastfeeding appearing as the primary indexed condition, and to 0 interventions.
NCT06691932 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06691932 about?
NCT06691932 is a clinical study titled "At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)". The purpose of this study is to define human milk (HM) as an ecosystem which investigators will then combine into temporal models of milk dynamics to accurately describe HM chronobiology. This study addresses 4 crucial public health gaps: 1) how breast milk changes over time and over the day, 2) how...
What is the current status of trial NCT06691932?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2024-11-12. Estimated completion is 2029-11-01.
What conditions does trial NCT06691932 study?
This clinical trial studies the following conditions: Breastfeeding, Exclusive Breastfeeding.
Who is sponsoring clinical trial NCT06691932?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06691932 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06691932's enrollment target sits among peer trials
240 15th of 36 higher than 21 of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
RECRUITING
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Excretion of Rivaroxaban in Human Breast Milk
RECRUITING · Phase 1
-
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
RECRUITING
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI